Widely used:Recently Viewed
Clear All$0.48
$-0.01
(-1.84%)
As on 28-Apr-2025 09:30EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$16 Mln
P/E Ratio
--
P/B Ratio
0.55
Industry P/E
50.24
Debt to Equity
0
ROE
-0.13 %
ROCE
--
Div. Yield
125 %
Book Value
--
EPS
--
CFO
$-20.76 Mln
EBITDA
$370.27 Mln
Net Profit
$-111.34 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
| -32.68 | 12.75 | -26.80 | -54.20 | -42.73 | -29.49 | -16.45 |
|
BSE Sensex*
| 2.54 | 3.65 | 5.71 | 8.83 | 11.73 | 20.10 | 11.34 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
| -48.33 | -2.80 | -55.45 | 27.38 | -4.18 | -5.40 | -65.69 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 1.03 | 5.24 | -- | -156.75 |
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays,... biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. Address: 21 Executive Blvd, Farmingdale, NY, United States, 11735 Read more
Chief Executive Officer
Ms. Kara Cannon
CEO & Director
Ms. Kara Cannon
Headquarters
Farmingdale, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Enzo Biochem Inc ($001 Par Value) (ENZ) stood at $ 85 Mln as on 31-Jan-25
The share price of Enzo Biochem Inc ($001 Par Value) (ENZ) is $0.48 (NYSE) as of 28-Apr-2025 09:30 EDT. Enzo Biochem Inc ($001 Par Value) (ENZ) has given a return of -42.73% in the last 3 years.
Enzo Biochem Inc ($001 Par Value) (ENZ) has a market capitalisation of $ 16 Mln as on 28-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Enzo Biochem Inc ($001 Par Value) (ENZ) is 0.55 times as on 28-Apr-2025, a 79% discount to its peers’ median range of 2.59 times.
Since, TTM earnings of Enzo Biochem Inc ($001 Par Value) (ENZ) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Enzo Biochem Inc ($001 Par Value) (ENZ) and enter the required number of quantities and click on buy to purchase the shares of Enzo Biochem Inc ($001 Par Value) (ENZ).
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York. Address: 21 Executive Blvd, Farmingdale, NY, United States, 11735
The CEO & director of Ms. Kara Cannon. is Enzo Biochem Inc ($001 Par Value) (ENZ), and CFO & Sr. VP is Ms. Kara Cannon.
There is no promoter pledging in Enzo Biochem Inc ($001 Par Value) (ENZ).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1
|
| Enzo Biochem Inc. ($0.01 Par Value) (ENZ) | Ratios |
|---|---|
|
Return on equity(%)
|
-41.49
|
|
Operating margin(%)
|
-30.02
|
|
Net Margin(%)
|
-73.25
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Enzo Biochem Inc ($001 Par Value) (ENZ) was $0 Mln.
